| Literature DB >> 15175113 |
Walter L J M Devillé1, Joris C Yzermans, Nico P van Duijn, P Dick Bezemer, Daniëlle A W M van der Windt, Lex M Bouter.
Abstract
BACKGROUND: Many studies have evaluated the accuracy of dipstick tests as rapid detectors of bacteriuria and urinary tract infections (UTI). The lack of an adequate explanation for the heterogeneity of the dipstick accuracy stimulates an ongoing debate. The objective of the present meta-analysis was to summarise the available evidence on the diagnostic accuracy of the urine dipstick test, taking into account various pre-defined potential sources of heterogeneity.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15175113 PMCID: PMC434513 DOI: 10.1186/1471-2490-4-4
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Results of subgroup analyses and accuracy of nitrites in urine dipsticks for the diagnosis of urinary tract infections or bacteriuria according to several predefined study characteristics (subgroups of studies without information about the study characteristic at issue are not shown) (no. of studies: 46)
| BLINDING# | ||||
| not | 12 | 0.50 (0.43–0.59) | 0.89 (0.75–1.00) | 44 (19 – 139) |
| dipstick | 25 | 0.46 (0.38–0.56) | 0.91 (0.85–0.96) | 28 (27 – 30) |
| both | 8 | 0.55 (0.36–0.85) | 0.96 (0.94–0.98) | 99 (41 – 239) |
| DATA COLLECTION# | ||||
| prospective | 42 | 0.48 (0.42–0.55) | 0.91 (0.86–0.96) | 34 (21 – 57) |
| retrospective | 1 | 0.37 (0.28–0.46) | 1.00 (0.99–1.00) | 701 (43 – 11565) |
| CUT-OFF CRITERION STANDARD* | ||||
| <1000 mcu/ml | 5 | 0.62 (0.56–0.69) | 0.92 (0.84–1.00) | 32 (9 – 112) |
| 10.000–50.000 | 9 | 0.37 (0.28–0.48) | 0.93 (0.88–0.98) | 18 (6 – 51) |
| ≥100.000 | 34 | 0.48 (0.40–0.57) | 0.93 (0.87–0.98) | 50 (29 – 84) |
| POPULATION# | ||||
| general | 15 | 0.50 (0.44–0.58) | 0.82 (0.71–0.95) | 11 (6 – 21) |
| children | 10 | 0.50 (0.42–0.60) | 0.92 (0.87–0.98) | 34 (12 – 97) |
| pregnant women | 10 | 0.46 (0.38–0.56) | 0.98 (0.79–1.00) | 165 (73 – 372) |
| elderly | 3 | 0.71 (0.50–1.00) | 0.96 (0.91–1.00) | 108 (10 – 1165) |
| urology | 3 | 0.59 (0.53–0.66) | 0.97 (0.94–1.00) | 64 (19 – 216) |
| surgery | 3 | 0.54 (0.39–0.74) | 0.96 (0.93–0.99) | 34 (25 – 47) |
| SETTING# | ||||
| family physician | 6 | 0.53 (0.44–0.65) | 0.88 (0.81–0.96) | 12 (7 – 21) |
| outpatient | 17 | 0.45 (0.37–0.56) | 0.96 (0.92–0.99) | 87 (38 – 198) |
| emergency | 4 | 0.56 (0.40–0.81) | 0.94 (0.90–0.98) | 34 (10 – 112) |
| inpatient | 16 | 0.58 (0.51–0.67) | 0.85 (0.74–0.98) | 23 (10 – 54) |
| LEVEL OF CARE | ||||
| community | 2 | 0.18 (0.04–0.76) | 0.99 (0.98–1.00) | 78 (34 – 181) |
| primary | 12 | 0.49 (0.38–0.62) | 0.85 (0.73–1.00) | 22 (9 – 53) |
| secondary | 11 | 0.51 (0.40–0.66) | 0.89 (0.78–1.00) | 61 (15 – 247) |
| tertiary | 21 | 0.53 (0.46–0.60) | 0.94 (0.93–0.96) | 39 (22 – 69) |
DOR: diagnostic odds ratio, #: DOR significantly different between subgroups, *: If different cut-off points were used within one study population, the results were included as different studies (N = 48).
Post-test probabilities (predictive values) of dipstick nitrites, leucyte-esterase and combinations of both tests in population sub-groups and different settings, based on pooled sensitivities, pooled specificities and pooled pre-test probabilities (prevalences).
| Population | |||||
| General population | .15 | ||||
| - Test + | .33 | .27 | .31 | .89 | |
| - Test - | .90 | .91 | .94 | .91 | |
| Children | .20 | ||||
| - Test + | .61 | .34 | .58 | .66 | |
| - Test - | .88 | .88 | .95 | .87 | |
| Pregnant women | .06 | ||||
| - Test + | .55 | .10 | .58 | (.99) | |
| - Test - | .97 | .97 | .95 | (.96) | |
| Elderly | .30 | ||||
| - Test + | .88 | .47 | .55 | (.90) | |
| - Test - | .89 | .81 | .90 | (.86) | |
| Surgery | .15 | ||||
| - Test + | .70 | .27 | .51 | (.38) | |
| - Test - | .92 | .91 | .97 | (.94) | |
| Urology | .15 | ||||
| - Test + | .78 | .68 | .54 | ||
| - Test - | .93 | .97 | .98 | ||
| Setting | |||||
| Family physician | .55 | ||||
| - Test + | .84 | .62 | .76 | ||
| - Test - | .61 | .69 | .84 | ||
| Outpatient | .10 | ||||
| - Test + | .56 | .22 | .32 | ||
| - Test - | .94 | .94 | .97 | ||
| Inpatient | .15 | ||||
| - Test + | .41 | .38 | .38 | ||
| - Test - | .92 | .93 | .95 | ||
| Emergency | .15 | ||||
| - Test + | .62 | .41 | .41 | ||
| - Test - | .92 | .92 | .98 | ||
(): based on one study only.
Figure 1Predictive value (posttest probability) of positive and negative test results of respectively nitrites, leucocyte-esterase (only non-urological patients) and combination of both tests with at least one positive for the diagnosis of bacteriuria or UTI in different settings (for sensitivity and specificity values see Tables 1 to 3).
Figure 2Predictive value (posttest probability) of positive and negative test results of respectively nitrites, combination of both tests with at least one positive and combination of both tests with both tests positive for the diagnosis of bacteriuria or UTI in different populations (for sensitivity and specificity values see Tables 1 to 3).
Results of subgroup analyses and accuracy of leucocyte-esterase in urine dipsticks in the diagnosis of urinary tract infections or bacteriuria. (subgroups of studies without information about the study characteristic at issue are not shown) (no. of studies: 35)
| POPULATION# | ||||
| non-urological | 33 | 0.62 (0.54–0.71) | 0.70 (0.60–0.81) | 9 (6 – 12) |
| urological | 2 | 0.86 (0.68–1.00) | 0.93 (0.81–1.00) | 276 (2 – 41974) |
| NON-UROLOGICAL STUDIES (N = 33) | ||||
| DISEASE# | ||||
| bacteriuria | 8 | 0.56 (0.38–0.82) | 0.61 (0.41–0.90) | 5 (5 – 8) |
| UTI | 25 | 0.64 (0.56–0.74) | 0.73 (0.63–0.85) | 11 (6 – 19) |
| SETTING | ||||
| family physician | 6 | 0.87 (0.83–0.92) | 0.36 (0.21–0.64) | 5 (2 – 28) |
| outpatient | 12 | 0.50 (0.35–0.68) | 0.80 (0.72–0.88) | 8 (5 – 12) |
| emergency | 3 | 0.56 90.41–0.75) | 0.86 (0.74–0.99) | 14 (2 – 119) |
| inpatient | 11 | 0.66 (0.60–0.73) | 0.81 (0.74–0.88) | 11 (8 – 16) |
| LEVEL OF CARE | ||||
| community | 1 | 0.63 (0.08–1.00) | 0.85 (0.82–0.88) | 9 (1 – 72) |
| primary care | 10 | 0.76 (0.60–0.98) | 0.46 (0.32–0.68) | 6 (3 – 11) |
| secondary care | 8 | 0.48 (0.33–0.71) | 0.83 (0.73–0.93) | 8 (4 – 14) |
| tertiary care | 14 | 0.62 (0.55–0.70) | 0.84 (0.80–0.89) | 13 (8 – 20) |
| READER OF TEST | ||||
| family physician | 2 | 0.86 (0.71–1.00) | 0.17 (0.04–0.62) | 2 (0.3 – 10) |
| nurse | 7 | 0.67 (0.58–0.79) | 0.65 (0.37–1.00) | 7 (4 – 10) |
| clinician | 2 | 0.34 (0.18–0.64) | 0.90 (0.68–1.00) | 7 (0.5 – 87) |
| lab worker | 17 | 0.59 (0.47–0.73) | 0.81 (0.76–0.87) | 11 (7 – 18) |
DOR: diagnostic odds ratio; #: DOR significantly different between subgroups
Results of subgroup analyses and accuracy of combinations of both tests of nitrites and leucocyte-esterase in urine dipsticks in the diagnosis of urinary tract infections or bacteriuria (subgroups of studies without information about the study characteristic at issue are not shown).
| CUT-OFF CRITERION STANDARD#* | ||||
| ≥103 mcu/ml | 2 | 0.45 (0.00–1.00) | 0.62 (0.00–1.00) | 4 (0.8 – 15) |
| ≥104 mcu/ml | 11 | 0.67 (0.53–0.87) | 0.78 (0.73–0.84) | 12 (7 – 23) |
| ≥105 mcu/ml | 27 | 0.80 (0.76–0.86) | 0.80 (0.76–0.84) | 25 (17 – 38) |
| POPULATION# | ||||
| general population | 12 | 0.75 (0.61–0.93) | 0.70 (0.63–0.78) | 12 (6 – 22) |
| children | 9 | 0.83 (0.78–0.89) | 0.85 (0.79–0.91) | 46 (23 – 95) |
| pregnant women | 5 | 0.68 (0.58–0.78) | 0.87 (0.81–0.92) | 17 (10 – 30) |
| elderly | 4 | 0.82 (0.74–0.92) | 0.71 (0.55–0.71) | 16 (8 – 34) |
| surgery | 2 | 0.86 (0.84–0.88) | 0.86 (0.84–0.87) | 43 (22 – 85) |
| urology | 3 | 0.88 (0.76–1.00) | 0.87 (0.83–0.91) | 52 (48 – 56) |
| SETTING | ||||
| family physician | 2 | 0.90 (0.89–0.92) | 0.65 (0.61–0.69) | 18 (13 – 25) |
| outpatient | 13 | 0.75 (0.69–0.82) | 0.82 (0.77–0.87) | 18 (12 – 27) |
| emergency | 1 | 0.92 (0.86–0.98) | 0.83 (0.81–0.85) | 54 (25 – 117) |
| inpatient | 19 | 0.79 (0.69–0.91) | 0.77 (0.70–0.84) | 25 (14 – 46) |
| CLINICAL INFORMATION# | ||||
| Absent | 11 | 0.73 (0.58–0.91) | 0.75 (0.78–0.82) | 13 (7 – 25) |
| Present | 24 | 0.81 (0.77–0.87) | 0.79 (0.73–0.85) | 28 (18 – 44) |
| BRAND DIPSTICK# | ||||
| Multistix | 26 | 0.79 (0.71–0.87) | 0.77 (0.72–0.82) | 21 (13 – 33) |
| Chemstrips | 6 | 0.73 (0.61–0.87) | 0.86 (0.81–0.91) | 24 (12 – 50) |
| Combur | 1 | 0.78 (0.69–0.88) | 0.97 (0.96–0.97) | 102 (77 – 136) |
| CUT-OFF CRITERION STANDARD#* | ||||
| ≥103 mcu/ml | 1 | 0.45 (0.29–0.61) | 0.62 (0.50–0.74) | 1 (0.6 – 3) |
| ≥104 mcu/ml | 3 | 0.31 (0.16–0.60) | 0.96 (0.93–0.99) | 14 (5 – 41) |
| ≥105 mcu/ml | 12 | 0.44 (0.32–0.60) | 0.96 (0.92–1.00) | 75 (31 – 185) |
| POPULATION# | ||||
| general population | 3 | 0.45 (0.27–0.75) | 0.99 (0.98–1.00) | 15 (7 – 32) |
| children | 6 | 0.46 (0.30–0.71) | 0.94 (0.94–0.94) | 151 (51 – 448) |
| pregnant women | 1 | 0.17 (0.02–0.32) | 1.00 (0.99–1.00) | 429 (22 – 8210) |
| elderly | 1 | 0.63 (0.41–0.85) | 0.98 (0.92–1.00) | 89 (14 – 70) |
| surgery | 1 | 0.72 (0.64–0.80) | 0.77 (0.74–0.80) | 9 (6 – 13) |
| spinal | 1 | 0.47 (0.37–0.57) | 0.99 (0.97–1.00) | 72 (13 – 394) |
DOR: diagnostic odds ratio; #: DOR significant different between several subgroups; *: when in a study different cut-off points were used within one study population, the analyses were included as different studies